Search Results 81-90 of 16372 for Hypocalcemia

  1. Hypoparathyroidism Clinical Trials - Mayo Clinic Research

    This is a prospective, observational disease and drug registry designed to evaluate the safety and effectiveness profile of rhPTH(1-84) under conditions of ...

  2. Calcium release deficiency syndrome (CRDS) - Mayo Clinic

    The purpose of this research study is to establish a large registry of individuals diagnosed with CRDS, along with individuals that have genetic changes that ...

  3. Nilotinib (oral route) - Mayo Clinic

    Hypocalcemia (low calcium in the blood) or; Hyponatremia (low sodium in the blood) or; Hypophosphatemia (low phosphate in the blood) or; Lung disease (eg ...

  4. What affects bone health? · The amount of calcium in your diet. A diet low in calcium may lead to low bone density, early bone loss and easily broken bones.

  5. Sodium polystyrene sulfonate (oral route, route not applicable) - Mayo Clinic

    Hypocalcemia (low calcium in the blood) or; Hypokalemia (low potassium in the blood); Hypomagnesemia (low magnesium in the blood)—Use with caution. May make ...

  6. Study of Intravenous Sodium Thiosulfate in Acute Calciphylaxis Patients - Mayo Clinic

    Baseline abnormalities related to QT prolongation (corrected QT interval > 470 ms), hypocalcemia (serum albumin-corrected calcium < 8 mg/dL ), metabolic ...

  7. Publications - Tom D. Thacher, M.D. - Mayo Clinic

    ... Hypocalcemia and the Role of Vitamin D Deficiency. J Pediatr. 2019 Aug; 211 ... Cardiac, bone and growth plate manifestations in hypocalcemic infants: revealing ...

  8. Lanreotide (subcutaneous route) - Mayo Clinic

    Lanreotide injection is used for the long-term treatment of acromegaly (a growth hormone disorder) in patients who cannot be treated with surgery or radiation.

  9. Publications - Sandhya Manohar, M.B.B.S. - Mayo Clinic

    ... hypocalcemia: meta-analysis. Nephrol Dial Transplant. 2019 Jan 1; 34 (1):108-117. View PubMed; Kompotiatis P, Thongprayoon C, Manohar S, Cheungpasitporn W ...

  10. A pivotal study of derazantinib in patients with inoperable or advanced intrahepatic cholangiocarcinoma and FGFR2 gene fusions or FGFR2 gene mutations or amplifications - Mayo Clinic

    Hypocalcemia: corrected serum calcium < 1.75 mmol/L (< 7.0 mg/dL);; Hypomagnesemia: < 0.4 mmol/L (< 0.9 mg/dL). Significant gastrointestinal disorder(s) that ...